Literature DB >> 27259748

Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson's disease.

Zi-Jiao Yang1, Jing Wei2, Cheng-Jie Mao1, Jin-Ru Zhang1, Jing Chen1, Xiao-Yan Ji2, Jun-Yi Liu3, Yun Shen1, Kang-Ping Xiong1, Jun-Ying Huang1, Ya-Ping Yang1,3, Chun-Feng Liu4,5,6.   

Abstract

PURPOSE: Retinal nerve fiber layer (RNFL) thinning occurs in Parkinson's disease (PD) and other neurodegenerative diseases. Idiopathic RBD (iRBD) is a well-established prodromal hallmark of synucleinopathies and occurs secondary to many neurodegenerative diseases, including PD. The aim of this study is to determine whether or not retinal structures are altered with the onset of rapid eye movement (REM) sleep behavior disorders (RBD).
METHODS: In all, a total of 63 patients with PD, 14 patients with idiopathic RBD, and 26 sex- and age-matched healthy controls were enrolled and underwent optical coherence tomography measurements (HD-OCT (Zeiss) ) for the average and every quadrant of RNFL thickness. The REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ) was used to classify PD patients with clinically probable RBD (PD + pRBD) or without probable RBD (PD - pRBD). Patients with iRBD were identified by polysomnography.
RESULTS: For patients with RBD (idiopathic or secondary to PD), we found a significant decrease in RNFL thickness compared with groups without RBD (PD - pRBD and healthy controls) (all p < 0.05). Average RNFL thickness in patients with iRBD is significantly thinner than in healthy controls (p < 0.05). In PD, the average RNFL thickness was dramatically thinner in the PD + pRBD group than the PD - pRBD group (p < 0.005). Compared with healthy controls, RNFL thickness was slightly thinner in the drug-naive PD group but not the PD group with drug treatment. Multiple linear regression analysis showed that RBDSQ score was negatively associated with average and inferior RNFL variation in PD (all p < 0.005).
CONCLUSIONS: The findings show that RNFL was slightly but significantly thinner in idiopathic RBD. In PD, RNFL thickness may vary depending on the presence of RBD.

Entities:  

Keywords:  Idiopathic rapid eye movement sleep behavior disorders; Optical coherence tomography measurement; Parkinson’s disease; Rapid eye movement sleep behavior disorders; Retinal nerve fiber layer thickness

Mesh:

Year:  2016        PMID: 27259748     DOI: 10.1007/s11325-016-1366-4

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  31 in total

Review 1.  The role of retinal regulation of sleep in health and disease.

Authors:  Conrad Schmoll; Gerassimos Lascaratos; Bal Dhillon; Debra Skene; Renata L Riha
Journal:  Sleep Med Rev       Date:  2010-10-30       Impact factor: 11.609

2.  Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.

Authors:  Thomas G Beach; Jeremiah Carew; Geidy Serrano; Charles H Adler; Holly A Shill; Lucia I Sue; Marwan N Sabbagh; Haruhiko Akiyama; Nicolás Cuenca
Journal:  Neurosci Lett       Date:  2014-04-28       Impact factor: 3.046

3.  Sleep-related injury in the elderly--an epidemiological study in Hong Kong.

Authors:  H F Chiu; Y K Wing; L C Lam; S W Li; C M Lum; T Leung; C K Ho
Journal:  Sleep       Date:  2000-06-15       Impact factor: 5.849

4.  Dopamine: a retinal neurotransmitter. II. Autoradiographic localization of H3-dopamine in the retina.

Authors:  S G Kramer; A M Potts; Y Mangnall
Journal:  Invest Ophthalmol       Date:  1971-08

5.  Polysomnographic diagnosis of idiopathic REM sleep behavior disorder.

Authors:  Jacques Montplaisir; Jean-Francois Gagnon; Maria Livia Fantini; Ronald B Postuma; Yves Dauvilliers; Alex Desautels; Sylvie Rompré; Jean Paquet
Journal:  Mov Disord       Date:  2010-10-15       Impact factor: 10.338

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Parkinson's disease and REM sleep behavior disorder result in increased non-motor symptoms.

Authors:  Ariel B Neikrug; Julie A Avanzino; Lianqi Liu; Jeanne E Maglione; Loki Natarajan; Jody Corey-Bloom; Barton W Palmer; Jose S Loredo; Sonia Ancoli-Israel
Journal:  Sleep Med       Date:  2014-05-10       Impact factor: 3.492

8.  Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients.

Authors:  M Satue; E Garcia-Martin; I Fuertes; S Otin; R Alarcia; R Herrero; M P Bambo; L E Pablo; F J Fernandez
Journal:  Eye (Lond)       Date:  2013-02-22       Impact factor: 3.775

Review 9.  Optical coherence tomography in Parkinson's disease: is the retina a biomarker?

Authors:  Jee-Young Lee; Jeeyun Ahn; Tae Wan Kim; Beom Seok Jeon
Journal:  J Parkinsons Dis       Date:  2014       Impact factor: 5.568

10.  Circadian clock disruption in neurodegenerative diseases: cause and effect?

Authors:  Erik S Musiek
Journal:  Front Pharmacol       Date:  2015-02-27       Impact factor: 5.810

View more
  4 in total

Review 1.  Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism.

Authors:  Hong Jin; Jin-Ru Zhang; Yun Shen; Chun-Feng Liu
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

2.  Dopaminergic Basis of Spatial Deficits in Early Parkinson's Disease.

Authors:  B Hanna-Pladdy; R Pahwa; K E Lyons
Journal:  Cereb Cortex Commun       Date:  2021-06-24

Review 3.  Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.

Authors:  Jee-Young Lee; Antonio Martin-Bastida; Ane Murueta-Goyena; Iñigo Gabilondo; Nicolás Cuenca; Paola Piccini; Beomseok Jeon
Journal:  Nat Rev Neurol       Date:  2022-02-17       Impact factor: 44.711

Review 4.  Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder.

Authors:  Mitchell G Miglis; Charles H Adler; Elena Antelmi; Dario Arnaldi; Luca Baldelli; Bradley F Boeve; Matteo Cesari; Irene Dall'Antonia; Nico J Diederich; Kathrin Doppler; Petr Dušek; Raffaele Ferri; Jean-François Gagnon; Ziv Gan-Or; Wiebke Hermann; Birgit Högl; Michele T Hu; Alex Iranzo; Annette Janzen; Anastasia Kuzkina; Jee-Young Lee; Klaus L Leenders; Simon J G Lewis; Claudio Liguori; Jun Liu; Christine Lo; Kaylena A Ehgoetz Martens; Jiri Nepozitek; Giuseppe Plazzi; Federica Provini; Monica Puligheddu; Michal Rolinski; Jan Rusz; Ambra Stefani; Rebekah L S Summers; Dallah Yoo; Jennifer Zitser; Wolfgang H Oertel
Journal:  Lancet Neurol       Date:  2021-08       Impact factor: 44.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.